文献速递其他结缔组织病

CXCL13作为干燥综合征组织学受累的生物标志物

CXCL13 as biomarker for histological involvement in Sjögren's syndrome.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

本研究在罗马和英国两个独立队列共109例干燥综合征患者中,评估血清CXCL13水平与唇腺活检组织病理学参数的关系。结果显示患者血清CXCL13高于对照,且与浸润灶大小及生发中心形成相关,提示其可作为监测局部病理程度的血清标志物。

要点

  • 干燥综合征患者血清CXCL13水平高于对照组。
  • CXCL13与唇腺浸润灶大小及生发中心存在相关。
  • CXCL13有望作为监测局部B细胞活化的血清标志物。

核心结论

  • 血清CXCL13水平与干燥综合征唇腺组织学受累程度相关,可作为监测局部病理的候选血清标志物。

研究设计与样本

  • 研究纳入109例干燥综合征患者,分别来自罗马Sapienza大学(n=60)和英国伯明翰伊丽莎白女王医院及伦敦Barts Health NHS Trust(n=49),均有血清和匹配的唇腺活检标本。
  • 对照组包括57例口干眼干患者和19例健康受试者的血清。

主要发现

  • 干燥综合征患者血清CXCL13水平高于对照组。
  • 血清CXCL13水平与唇腺组织病理学参数(包括浸润灶大小和生发中心存在)存在相关性。

临床怎么用

  • CXCL13可作为监测干燥综合征患者局部病理程度的潜在血清标志物,但需在纵向临床研究中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: SS is an autoimmune condition characterized by systemic B-cell activation, autoantibody production and ectopic germinal centres' formation within the salivary gland (SG). The extent of SG infiltrate has been proposed as a biomarker of disease severity. Plasma levels of CXCL13 correlate with germinal centres' activity in animal models and disease severity in SS, suggesting its potential use as a surrogate serum marker to monitor local B-cell activation. The aim of this study was to evaluate the potential role of CXCL13 as a biomarker of SG pathology in two independent SS cohorts. METHODS: 109 patients with SS were recruited at Sapienza University of Rome (Italy) (n = 60), or at Queen Elizabeth Hospital in Birmingham and Barts Health NHS Trust in London (n = 49). Both sera and matched minor SG biopsy were available. Sicca (n = 57) and healthy subjects' (n = 19) sera were used as control. RESULTS: CXCL13 serum level was higher in SS patients compared with controls. Correlations between its serum levels and a series of histomorphological parameters, including size of the aggregates and the presence germinal centres', were observed. CONCLUSION: Our data foster the use of CXCL13 to monitor the extent of local pathology in SS and its validation in longitudinal clinical studies.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Colafrancesco S, Priori R, Smith CG, et al. CXCL13 as biomarker for histological involvement in Sjögren's syndrome. Rheumatology (Oxford). 2020. PMID: 31274159. doi:10.1093/rheumatology/kez255

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。